224 related articles for article (PubMed ID: 1974402)
1. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
[TBL] [Abstract][Full Text] [Related]
2. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
Frostad AB; Olsen AK
Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
[TBL] [Abstract][Full Text] [Related]
3. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of topical levocabastine compared with oral terfenadine.
Bahmer FA; Ruprecht KW
Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis.
Palma-Carlos AG; Chieira C; Conde TA; Cordeiro JA
Ann Allergy; 1991 Oct; 67(4):394-8. PubMed ID: 1683189
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
Abelson MB; Greiner JV
Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
[TBL] [Abstract][Full Text] [Related]
8. Levocabastine eye drops versus sodium cromoglycate in seasonal allergic conjunctivitis.
Wihl JA; Rudblad S; Kjellén H; Blychert LA
Clin Exp Allergy; 1991 May; 21 Suppl 2():37-8. PubMed ID: 1680537
[No Abstract] [Full Text] [Related]
9. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis.
Odelram H; Björkstén B; af Klercker T; Rimås M; Kjellman NI; Blychert LO
Allergy; 1989 Aug; 44(6):432-6. PubMed ID: 2572181
[TBL] [Abstract][Full Text] [Related]
10. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis.
Pipkorn U; Bende M; Hedner J; Hedner T
Allergy; 1985 Oct; 40(7):491-6. PubMed ID: 2866725
[TBL] [Abstract][Full Text] [Related]
11. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests.
Rimås M; Kjellman NI; Blychert LO; Björkstén B
Allergy; 1990 Jan; 45(1):18-21. PubMed ID: 1968726
[TBL] [Abstract][Full Text] [Related]
12. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
Davies BH; Mullins J
Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
Vermeulen J; Mercer M
Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 0.05% levocabastine versus 4% sodium cromolyn in the allergen challenge model.
Abelson MB; George MA; Smith LM
Ophthalmology; 1995 Feb; 102(2):310-6. PubMed ID: 7862419
[TBL] [Abstract][Full Text] [Related]
15. A double-blind clinical trial wtih cromoglycate eye drops in patients with atopic conjunctivitis.
Simon-Licht IF; Dieges PH
Ann Allergy; 1982 Oct; 49(4):220-4. PubMed ID: 6812469
[TBL] [Abstract][Full Text] [Related]
16. [Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study].
Graue E
Gac Med Mex; 1994; 130(6):481-6. PubMed ID: 7557064
[TBL] [Abstract][Full Text] [Related]
17. Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro.
Buscaglia S; Paolieri F; Catrullo A; Fiorino N; Riccio AM; Pesce G; Montagna P; Bagnasco M; Ciprandi G; Canonica GW
Clin Exp Allergy; 1996 Oct; 26(10):1188-96. PubMed ID: 8911706
[TBL] [Abstract][Full Text] [Related]
18. The role of levocabastine in the treatment of allergic rhinoconjunctivitis.
Knight A
Br J Clin Pract; 1994; 48(3):139-43. PubMed ID: 7913336
[TBL] [Abstract][Full Text] [Related]
19. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
Dechant KL; Goa KL
Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
[TBL] [Abstract][Full Text] [Related]
20. Clobetasone treatment of allergic conjunctivitis: a comparative double blind study.
Cerqueti PM; Prosio PE; Bosia S; Buscaglia S; Ciprandi G
Allergol Immunopathol (Madr); 1993; 21(2):67-70. PubMed ID: 8337991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
